Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Mirza Mansoor Raza received 38,817 Acrivon Therapeutics, Inc. shares as an award (Form 4)
Traded May 18, 2026 · Filed May 20, 2026
On May 18, 2026, Mirza Mansoor Raza (Chief Medical Officer) received 38,817 Acrivon Therapeutics, Inc. shares as an award, leaving 38,817 shares. Filed May 20, 2026 (Form 4).
- Awarded
- 38,817 shares
- Holding after
- 38,817 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Award | 38,817 | 38,817 | Direct |